Scientists at UCSF have uncovered how certain immune cells in the brain, called microglia, can effectively digest toxic ...

Microglia, a type of brain immune cell, can gobble up amyloid beta protein, which clumps together into toxic aggregates ...

ALZpath’s pTau217 antibody was released in 2023 and continues to be a key focus in Alzheimer’s disease research and ...

The Alzheimer's Association® will present 10 scientific awards at the Alzheimer's Association International Conference® 2025 (AAIC®), recognizing researchers for their expertise, noteworthy ...

Although it's not always easy to determine if an individual can make decisions, a judge understands the obvious that a ...

Researchers say the repurposed drugs could accelerate a long-stalled path toward meaningful Alzheimer’s treatment. (Scripps ...

Aggression in Alzheimer’s can’t always be prevented, but it can often be de-escalated when it occurs. Each person is unique. What works for your loved one may not be as effective for someone else.

However, unlike most clinical studies, no treatment is tested in ADNI. Instead, participants are followed over a period of years or decades with repeated imaging, including MRI and PET amyloid and tau ...

Case Western Reserve researchers find that for every 1,000 seniors who had covid, seven will be diagnosed with Alzheimer’s disease within a year, slightly above the five-in-a-thousand diagnosis ...

Nov 14 (Reuters) - Roche's (ROG.S) Alzheimer's drug candidate could not be shown to slow dementia progression in two drug trials, leaving rivals Biogen (BIIB.O) and Eisai (4523.T) as leaders in a ...

Alzheimer’s disease could soon be a distant memory. A revolutionary new Alzheimer’s drug named lecanemab could mark a major breakthrough in the decades-long battle against the neurological ...